TERUMO HX2 TEMPERATURE MANAGEMENT SYSTEM

K071521 · Terumo Cardiovascular Systems Corp. · DWC · Nov 21, 2007 · Cardiovascular

Device Facts

Record IDK071521
Device NameTERUMO HX2 TEMPERATURE MANAGEMENT SYSTEM
ApplicantTerumo Cardiovascular Systems Corp.
Product CodeDWC · Cardiovascular
Decision DateNov 21, 2007
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 870.4250
Device ClassClass 2
AttributesTherapeutic

Intended Use

The Terumo® HX2™ Temperature Management System is indicated for use to supply temperature regulated water to heat exchangers during open heart surgery.

Device Story

Terumo HX2 Temperature Management System provides temperature control for two independent water circuits used in cardiopulmonary bypass surgery. System components include water tank, circulating pumps, heater manifolds, temperature sensors, water detectors, and mixing valves. Device accepts manual ice addition for cooling; uses internal heaters for heating. System circulates water at minimum 6.5 gal/min. Software regulates temperatures to user-defined setpoints, performs diagnostics, and provides visual/audible fault alerts. Used in OR by perfusionists/clinicians. Output consists of temperature-regulated water delivered to heat exchangers, affecting patient blood and cardioplegia solution temperature. Benefits include precise, independent thermal management of two circuits, improved priming/draining, and digital diagnostic feedback compared to legacy systems.

Clinical Evidence

Bench testing only. Performance characteristics of the HX2 system were exhaustively tested and compared against Sarns Dual Cooler/Heater and Sarns TCM II. All new and existing performance characteristics were validated to confirm the device performs as intended according to specifications.

Technological Characteristics

System utilizes two independent water circuits with thermistor and RTD temperature sensors. Features include water tank, circulating pumps, heater manifolds, and mixing valves. Connectivity includes digital display for setpoints and diagnostics. Software-controlled automated heating and cooling. Dimensions/form factor support transport on inclines up to 15 degrees. Mercury-free design.

Indications for Use

Indicated for use in open heart surgery to supply temperature-regulated water to heat exchangers for patient blood and cardioplegia solution temperature control.

Regulatory Classification

Identification

A cardiopulmonary bypass temperature controller is a device used to control the temperature of the fluid entering and leaving a heat exchanger.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ ## NOV 2 1 2007 Image /page/0/Picture/2 description: The image shows the logo for Terumo Cardiovascular Systems. The logo consists of a circle with the letter "T" inside, followed by the word "TERUMO" in bold, sans-serif font. Below the word "TERUMO" is the phrase "Cardiovascular Systems" in a smaller, sans-serif font. The logo is black and white. #### 510(k) SMDA Summary This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92. The assigned 510(k) Number is | Submitters Name: | Terumo Cardiovascular Systems Corporation | |---------------------|----------------------------------------------------| | Submitters Address: | 6200 Jackson Road, Ann Arbor, Michigan 48103-9300 | | Contact Person: | Mark A. Bur | | Phone Number: | (734) 741-6117 | | FAX Number: | (734) 663-5062 | | Summary Date: | May 30, 2007 | Device Trade Name: Terumo® HX2™ Temperature Management System Common Name: Temperature Management System (TMS) Device Classification Name: Cardiopulmonary Bypass Temperature Controller (21 CFR 870.4250) Legally Marketed Predicate Device: Sarns TM Dual Cooler/Heater (Preamendment) Sarns ™ Temperature Control and Monitor System (TCM II) (K883603) Indications for Use: The Terumo® HX2™ Temperature Management System is indicated for use to supply temperature regulated water to heat exchangers during open heart surgery. | Operation | 10° to 40°C, less than 75% relative humidity, non condensing | |--------------|----------------------------------------------------------------------------------------------------| | Storage | Ventilated area, -30° to 54° C (-22 to 130°F), less than 95% relative<br>humidity, non-condensing. | | Transporting | Units may be transported up or down an incline up to 15 degrees<br>without tipping. | #### Device Description: The Terumo® HX2™ Temperature Management System provides temperature control of two independent water circuits that directly control the temperature of patient blood and cardioplegia solution during cardiovascular bypass surgery. The system consists of a water tank, circulating pumps, heater manifolds, mercury free temperature sensors, water detectors, mixing valves and a tank divider which is provided to partition the tank into two separate channels (Left and Right). The system will have the capacity to circulate water at least 6.5 gal/min (25 L/min) with no load connected. The system is capable of heating and cooling for a single channel or for both channels. Traditional 510(k) Terumo® HX2™ Temperature Management System Terumo Cardiovascular Systems Corporation Section 03: Page 03-1 {1}------------------------------------------------ Image /page/1/Picture/1 description: The image shows the logo for Terumo Cardiovascular Systems. The logo consists of a circle with the letter "T" inside, followed by the word "TERUMO" in bold, sans-serif font. Below the word "TERUMO" is the phrase "Cardiovascular Systems" in a smaller font. The logo is black and white. Channels are configurable such that different waterlice mixture ratios can be obtained. Manually added ice is the only means of obtaining the cool water supply. If a channel should fail during use, the user may switch the water hose connections to the other channel allowing the user to be operational in less than or equal to a minute. Software is used to adjust and display channel set temperatures, acquire and display actual temperatures, automatically regulate temperatures to the entered setpoint, perform system diagnostics, and present visual and audible indications of faults that may occur. #### Technological Characteristics: The Terumo® HX2™ Temperature Management System is a combination of the technologies from the current legally marked devices, Sarns™ Dual Cooler/Heater and the Sams™ Temperature Control and Monitor System (TCM II) and the present day technologies and a computer. The main differences between the predicate devices, Sarns™ Dual Cooler/Heater and the Sarns™ Temperature Control and Monitor System (TCM II) and the Terumo® HX2 ™ Temperature Management System are: - · old Hg-added switches used in predicates replaced with thermosistors and rtd temperature sensors, - · old single channel of Dual Cooler Heater and 2 dependent channels of TCM II compared to 2 independent channels with equal capability. - · automated control of the new system for both heating and cooling compared to predicates manual control. - · improvements to the priming and draining of the new system compared to both predicates, - · range of user temperature setpoints for both channels compared to predicate (4) hardware limited setpoints, - · new system diagnostics will display error codes compared to no indications for the Dual Cooler Heater and only LED visual indicators on the TCM II, - · temperature display accuracy better than analog temperature display on Dual Cooler Heater. #### Non-clinical Performance: The performance characteristics of the Terumo® HX2 ™ Temperature Management System were exhaustively tested and compared with the performance characteristics of the currently marketed Sarns™ Dual Cooler/Heater and the Sarns™ Temperature Control and Monitor System (TCM II). All new and existing performance characteristics of the Terumo® HX2™ Temperature Management System have been validated. #### Conclusion from Conducted Testing: The Terumo® HX2 ™ Temperature Management System performed as intended according to its performance specifications. The Terumo® HX2™ Temperature Management System is substantially equivalent to its predicate devices. {2}------------------------------------------------ Public Health Service Image /page/2/Picture/2 description: The image shows the logo for the Department of Health & Human Services - USA. The logo consists of a circular border with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the circumference. Inside the circle is a stylized image of an eagle or bird-like figure with three curved lines representing its wings or feathers. NOV 2 1 2007 Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Terumo Cardiovascular Systems Corp. c/o Mr. Mark A. Bur 6200 Jackson Rd. Ann Arbor, MI 48103 Re: K071521 Terumo HX2 Temperature Management System Regulation Number: 21 CFR 870.4250 Regulation Name: Cardiopulmonary bypass temperature controller Regulatory Class: Class II (two) Product Code: DWC Dated: November 8, 2007 Received: November 9, 2007 Dear Mr. Bur: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {3}------------------------------------------------ #### Page 2 - Mr. Mark Bur Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours, Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ # Indications for Use | 510(k) Number (if known): | K271521 | |---------------------------|---------| |---------------------------|---------| Terumo® HX2™ Temperature Management System Device Name: ### Indications For Use: The Terumo® HX2™ Temperature Management System is indicated for use to supply temperature regulated water to heat exchangers during open heart surgery. 10° to 40°C, less than 75% relative humidity, non-condensing. Operation Ventilated area, -30° to 54°C (-22 to 130°F), less than 95% Storage relative humidity, non-condensing. Transporting Units may be transported up or down an incline of up to 15 degrees without tipping. Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) QgmQ diovascular Devices K011521 510(k) Number. Traditional 510(k) -Terumo® HX2™ Temperature Management System Terumo Cardiovascular Systems Corporation Section 02: Page 02 - 1
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%